Healthcare Global Enterprises Limited has informed the Exchange about Investor Presentation
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
HCG has filed its investor presentation for Q1FY26 results with the exchanges. Revenue grew 17% YoY to Rs 6,132 Mn, driven by 17% growth in HCG Centers (Established +16%, Emerging +24%). Adjusted EBITDA rose 20% to Rs 1,118 Mn with margin expanding 56 bps to 18.2%. However, Profit After Tax declined 56% YoY to Rs 77 Mn (Pre-Ind AS) and 61% to Rs 47 Mn (Post-Ind AS), turning EPS negative at Rs -0.01, hurt by higher finance costs and depreciation. Net debt rose Rs 914 Mn in the quarter to Rs 7,231 Mn due to ESOP settlement. Operating metrics improved with bed capacity rising to 2,189 and LINAC utilization at 62%. Digital channel revenues grew 45% YoY.
Operating performance is strong with consistent revenue growth and margin expansion, but sharp PAT decline and rising net debt may concern investors in the short term. The margin improvement guidance and capacity additions support the long-term growth story, though profitability remains under pressure from elevated finance costs.